Hook & thesis
Oracle has been through the wringer: shares are roughly 54% below the 52-week high of $345.72, and the market is fretting about a massive capex cycle that pushed free cash flow negative. That headline is scary, but it also creates a tactical opportunity. The company still runs durable enterprise software economics, is growing cloud revenue at a rapid clip, and now trades at a valuation that already discounts execution risk. I think Oracle deserves one last chance as a tactical long with strict risk controls.
We want to own the stock into two things playing out in the next several months: 1) a rationalization of capex as the AI infrastructure build phase moves from hyper-scaling to steady state, and 2) continued monetization of Oracle's enterprise cloud and applications. This is not a buy-and-forget idea. It is a structured trade: entry at $163.27, stop at $145.00, target $210.00, horizon long term (180 trading days).
The business and why the market should care
Oracle operates across three segments: Cloud and License, Hardware, and Services. Its Cloud and License arm is the revenue engine—delivering cloud services, software licenses, and support—while Hardware and Services round out infrastructure and professional offerings. Enterprises still pay for mission-critical systems, and Oracle's installed base and enterprise relationships remain a high-quality moat.
Why should investors care now? Because the company has doubled down on AI infrastructure to capture a rare secular shift toward enterprise AI. Management reported roughly 17% revenue growth and 77% cloud infrastructure growth in recent commentary, illustrating strong demand. That demand is predictable in the sense of enterprise contracts and renewals, but the timing of cash returns depends on how quickly capex reverts from a build phase to a maintenance cadence.
Hard numbers that matter
| Metric | Value |
|---|---|
| Current price | $163.27 |
| Market cap | $470.15B |
| Price / Earnings | ~27.24x |
| EPS | $5.90 |
| Free cash flow | -$23.686B |
| Capital expenditures (reported) | $55.7B (capex spike to build AI infra) |
| EV / EBITDA | 17.51 |
| Debt / Equity | ~3.05 |
| Dividend | $0.50 per share (yield ~1.26%) |
Two numbers stand out: the negative free cash flow of roughly -$23.7B and the capex of $55.7B. Those moves explain the share-price rout, but they also correspond to an explicit strategic investment in AI infrastructure that drives long-term optionality if Oracle can monetize capacity and sell higher-margin services on top.
Valuation framing
Oracle's market cap of about $470B and enterprise value near $555B imply an EV/EBITDA of 17.5x. That's not cheap for a software-heavy company, but it is materially cheaper than the multiples at the 52-week high of $345.72. The multiple already bakes in concerns over cash generation because the recent negative free cash flow is embedded in forward expectations. At a P/E around 27x on trailing EPS of $5.90, the stock sits in a middle ground: expensive for a cyclical hardware cycle, reasonable for a large-cap software franchise with 17% revenue growth.
Two valuation points to keep in mind:
- Oracle's return on equity is very high (~40%), which signals excellent profitability on book equity even as capex skews cash flow short term.
- Debt/equity near 3.05 is elevated; investors are paying for growth funded by balance-sheet leverage during an aggressive build-out.
Catalysts
- Capex normalization - If capex begins to downshift from the $55.7B build phase toward a maintenance rate, free cash flow should rebound materially within a 1-2 quarter window.
- Earnings season and guidance - Oracle reports early in the Q3 cycle (expected to kick off on 09/10/2026). Better-than-feared guidance around cloud ARR and margin trajectory would re-rate the stock.
- Large-contract wins / renewals - Continued enterprise AI adoption and multi-year cloud deals would convert backlog into predictable revenue and margins.
- Improving sentiment around balance sheet management - any signs that management will reduce leverage or slow capex without sacrificing growth would be a near-term positive.
Trade plan (actionable)
Direction: Long
Entry: $163.27
Target: $210.00
Stop loss: $145.00
Horizon: long term (180 trading days) - this trade gives management time to show capex moderation, and to see whether AI-driven cloud revenue translates into cash. Expect two reported quarters and the next guidance cycle to matter.
Why these levels? Entry at $163.27 captures the current pullback and aligns with momentum indicators showing the stock above short-term moving averages (10-day SMA ~$150.84, 50-day SMA ~$140.13). The stop at $145 sits beneath a logical support band and limits downside to a controlled percentage while respecting technical structure. The $210 target is a pragmatic re-rating - not a return to the 52-week high but a ~29% upside from entry that compensates for the balance-sheet and cash-flow risk if capex normalizes and revenue/margin cadence reaccelerates.
Technical backdrop
Momentum indicators are constructive: the 9-day EMA (~$152.70) and 21-day EMA (~$148.57) are below price, RSI sits near 63.8 (above neutral), and MACD shows bullish momentum. Average daily volume is elevated (~20.9M), but recent sessions show a mix of directional interest and heavy short-volume days, which could amplify moves in either direction.
Risks and counterarguments
This trade is not without material downsides. Consider these risks:
- Capex remains elevated: If Oracle needs to continue spending heavily to keep pace, negative free cash flow could persist and pressure multiples further.
- Demand disappointment: Enterprise AI adoption could slow or customers could favor competitors, slowing ARR growth and hurting unit economics.
- Balance-sheet strain: Debt/equity near 3.05 is high; if markets tighten or rates spike, refinancing or interest costs could weigh on earnings.
- Execution risk: Converting new infrastructure into profitable, recurring cloud revenue requires sales and cost discipline — integration missteps would be punished.
- Macro risk: Broader market risk-off or another tech-sector rotation could pull Oracle down even if company fundamentals improve.
Counterargument: The bear case is that Oracle’s capex spree was ill-timed or misallocated and that the negative free cash flow is a structural problem, not a temporary phase. That is a reasonable view — this trade respects that possibility with a stop at $145.00. If you believe capex growth is permanent and that Oracle cannot monetize infrastructure as expected, this is not the trade for you.
What would change my mind
I will reassess the position if any of the following occur:
- Management signals sustained or increasing capex beyond current plans with no credible monetization path.
- Guidance for cloud ARR, bookings, or renewal rates deteriorates materially on the next earnings call (09/10/2026) relative to consensus.
- Balance-sheet deterioration accelerates: higher leverage, weaker liquidity ratios, or clear signs of stress in refinancing costs.
Conclusion
Oracle deserves one last chance from a tactical trading perspective. The firm remains a durable enterprise software company operating in an accelerating AI-secured market, and recent cash-flow weakness looks tied to an explicit, heavy capex phase to build AI infrastructure. The market has punished the stock accordingly, leaving room for a measured re-rate if capex normalizes and cloud monetization continues.
The trade is intentionally guarded: enter at $163.27, stop at $145.00, target $210.00, with a 180-trading-day horizon. This plan balances upside from operational recovery and sentiment improvement against real near-term cash and leverage risks. Keep position sizing conservative and watch the next earnings and guidance cycle closely.
Key upcoming date: earnings / guidance due to kick off 09/10/2026 — a potential catalyst for re-pricing.